Purchase Order 75N93023P01177

Award Date 8/31/23
Potential Completion Date 12/29/23
Potential Value $126K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marshallton, DE 19808, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $35,374.80 firm fixed-price purchase order contract to Agilent Technologies Inc.'s Customer Service And Sales Division for the delivery of SURE PRINT G3 MICROARRAY SLIDES. As the parent company, Agilent Technologies, Inc.'s Agilent Technologies Headquarters Division will also support performance under the contract. Place of performance will be in Marshallton,...
Agilent Technologies Inc. has been awarded a $7,458.91 firm fixed price delivery order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The order is for the provision of microarray and amplification kits to support the agency's research efforts. It was issued against Scientific Equipment and Services schedule contract FSS-66, held long-term by Agilent, and calls for delivery to Marshallton, Delaware by...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $50,352 fixed price purchase order contract to Agilent Technologies Inc. for the delivery of biological products in support of genomic research efforts. The contract calls for Agilent to provide four units of SureSelect Custom 1Kb-499kb capture kits, two kits of SSEL XT Low Input Reagent kits containing reagents for 1-96 samples, and two kits with reagents for 97-192 samples. All products are to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $134,674.04 firm-fixed-price delivery order contract to Agilent Technologies Inc. Customer Service And Sales Division for Agilent Microarray Kits. This order was placed under Agilent's existing General Services Administration (GSA) Federal Supply Schedule (FSS-66) contract for Scientific Equipment and Services. The contract has a performance period ending on...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $82,571.30 firm fixed-price purchase order to Agilent Technologies Inc. (Vendor ID: dGpVZjltbjNRWjIyd0wyb3VrUExuUT09) for Agilent array and labeling kits. The award, which does not have a set-aside designation, has an ultimate completion date of August 21, 2021. Agilent Technologies Inc. is a subsidiary of the parent company Agilent Technologies, Inc. (Vendor ID: SEVKMFUzK21PMEpteGRlNGVNTC9Zdz09), a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order for $9,995.15 to Agilent Technologies Inc. Customer Service And Sales Division for cellular imaging/microplate reader instrumentation. The contract has an award date of April 4, 2023 and a completion date of August 14, 2023. This purchase order is not associated with a set-aside program. Agilent Technologies Inc. is a global...
The U.S. Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $236,794.25 firm-fixed price delivery order to Agilent Technologies Inc. for the provision of Agilent microarray kits to support COVID-19 research. This award was made under Agilent's Multiple Award Schedule (MAS) contract with the General Services Administration. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $7,498.00 Firm Fixed Price Purchase Order to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of the Agilent Technologies, Inc. parent company. This award is for the delivery of a "CUSTOM 0.5-2.9MB LIBRARY SUFFICIENT FOR POST-CAPTURE PROCESSING OF 16 SAMPLES", with a completion date of September 20, 2017. The contract...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $119,898.77 firm fixed-price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for a CYTATION 7 Cell Imaging Multi-Mode Reader with Upright Microscope and Accessories. Place of performance will be Marshallton, Delaware through December 2023. This non-set aside award provides key cell imaging equipment in support of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,740 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for a CROSSLAB SILVER SERVICE CONTRACT FOR SEAHORSE XFE96 ANALYZER. As the parent company of Agilent Technologies Inc. Agilent Laboratory Division - doing business as Agilent Labs will provide support services for the Seahorse XFe96 Analyzer located in...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $126,095.20 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division. Under the terms of the contract, Agilent will provide 17 single lot-matched fluorescent DNA probe labeling kits, 100 lot-matched cDNA expression microarrays, gene expression hybridization and wash pack kits, and shipping and handling services in support of the agency's viral pathogenesis and evolution studies. The solicitation specifically sought these Agilent reagents to enable global expression analysis of nasal and blood samples from participants in a Phase II universal influenza vaccine clinical trial being conducted by the National Institute of Allergy and Infectious Diseases Laboratory of Infectious Disease in Bethesda, Maryland. Place of performance is Marshallton, Delaware and the period of performance spans from August 31, 2023 through December 29, 2023.

Generated 12/24/23, 12:55 PM